Parison Amy
SVP, Chief Financial Officer
Parison Amy has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Parison Amy is listed as SVP, Chief Financial Officer at Editas Medicine, Inc. Inside the rolling window, Parison Amy reported no open-market purchases and 5 open-market sales totaling $6K in EDIT. The largest disclosed transaction in the window is a sale of 678 EDIT shares on Aug 3, 2026, worth $2K.
Companies traded
Other insiders at EDIT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 3, 2025 | EDIT | Sale | $1K |
Frequently asked questions
How many SEC Form 4 filings has Parison Amy made?
Parison Amy has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Parison Amy trade?
Parison Amy has filed SEC Form 4 disclosures for 1 company, including EDIT.
When was Parison Amy's most recent SEC Form 4 filing?
Parison Amy's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Parison Amy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Parison Amy is listed as SVP, Chief Financial Officer.
What is Parison Amy's total buy and sell value in the current window?
Inside the rolling retention window, Parison Amy bought $0 and sold $6K based on SEC Form 4 filings.
What was Parison Amy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 678 EDIT shares on 2026-08-03, worth $2K, per SEC Form 4 filings.